Developer docs
API playgroundTry for free, no card

Search company profiles

MG Biologics

Full company profile

uuid000ae59

Namestring
MG Biologics
Legal namestring
MG Biologics
Websiteurl
mgbiologics.com
Company typeenum
Private
Founded yearint
1999
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAmes, United States
HQ citystring
Ames
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary biologics, equine plasma products, animal antivenom, USDA licensed antibodies, hyperimmune plasma manufacturing
Industry3 codes
PRIMARYHLAMAEAK
Biologics & Immunotherapies (Non-vaccine)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAB
Livestock & Production Animal Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAC
Equine Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Biologics
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Plasma and Antibody Products
TypeOne Time License
Description

One-time sale of plasma products (equine, canine, bovine, porcine) including USDA licensed products like ReSolution Rhodococcus Equi Antibody and High-Glo Equine IgG. Products sold directly and through distribution partners.

mgbiologics.com
2Rattler Antivenom
TypeOne Time License
Description

One-time sale of polyvalent antivenom for Crotalidae snakebites in canine, equine, and feline. Licensed product with three-year shelf life, sold in 50ml treatments.

mgbiologics.com
3Custom Blend Plasma
TypeOne Time License
Description

Custom designed ImmunoGlo plasma blends tailored to individual farm/farm veterinarian specifications. Pricing directly related to quantity per unit.

mgbiologics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1ImmunoGlo
Description

Custom blended plasma product line for equine use, allowing veterinarians to design donor vaccination histories.

mgbiologics.com
+7 more records
Core offering1 text field

MG Biologics is a USDA-licensed plasma and antibody manufacturer based in Ames, Iowa, that produces hyperimmune plasma products, IgG formulations, and polyvalent antivenom for veterinary use across equine, canine, bovine, porcine, and feline species. The company collects equine plasma from specifically vaccinated donors and manufactures biological products that deliver targeted antibodies to treat or prevent conditions such as Rhodococcus equi pneumonia, Failure of Passive Transfer in foals, Clostridium infections, enteric diseases, and pit viper envenomation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 80% protection against R. equi pneumonia with 2L hyperimmune plasma vs 68% with 1L
+4 more records
Product overview1 text field

MG Biologics is a USDA-licensed plasma and antibody manufacturer located in Ames, Iowa, offering a comprehensive portfolio of biological products for animal health. The product line centers on plasma-derived antibodies and antivenom products across multiple species including equine, canine, bovine, porcine, and feline. Key products include the ReSolution Rhodococcus Equi Antibody and High-Glo Equine IgG (both USDA licensed), the Rattler Antivenom polyvalent antivenom, TetriCare for tetanus protection, ACDCare for Clostridium perfringens coverage, Immunogut for canine enteric support, and AbSolution PG for porcine use. The ImmunoGlo Custom Blends platform allows veterinarians to design custom plasma formulations by selecting specific donor vaccination histories. Products range from single-pathogen plasmas to complex multi-pathogen blends available in volumes from 50ml to 1500ml.

Product and service9 records
1ReSolution Rhodococcus Equi Antibody
CategoryEquine Biologics - Plasma/Antibody
Description

USDA-licensed plasma product containing Virulence-Associated Plasmid A (VapA) antibodies with a minimum release titer of 1:10,000, used by veterinarians for prevention and control of Rhodococcus equi pneumonia in foals.

2High-Glo Equine IgG
CategoryEquine Biologics - IgG
Description

USDA-licensed intravenous treatment for Failure of Passive Transfer (FPT) in neonatal foals, supplementing IgG through plasma rich in immunoglobulin antibodies.

3Rattler Antivenom
CategoryVeterinary Antivenom
Description

Antivenom Crotalidae Polyvalent Equine Origin that neutralizes venom from rattlesnakes, copperheads, and cottonmouths/water moccasins including Mohave Venom A. Licensed for canine, equine, and feline use with a three-year shelf life.

4TetriCare
CategoryLivestock Biologics - Plasma
Description

Plasma from donors vaccinated against tetanus toxin for wound care management in cattle, horses, goats, sheep, and swine, available in 50 mL bottle and 200 mL IV bag formats.

5ACDCare
CategoryLivestock Biologics - Plasma
Description

Plasma from donors vaccinated against Clostridium perfringens Types A, C & D for cattle, goats, sheep, and swine, supporting gastrointestinal tract during high-stress situations.

6Immunogut
CategoryCanine Biologics - Oral Plasma
Description

Orally administered plasma from donors vaccinated against E. coli, Parvovirus, Salmonella, and Clostridioides difficile for canine support during enteric distress and high-stress situations.

7AbSolution PG
CategoryPorcine Biologics - Plasma
Description

Plasma from donors vaccinated against Clostridium difficile for porcine use to support intestinal health.

8ImmunoGlo Custom Blends
CategoryEquine Biologics - Custom Plasma
Description

Custom blended equine plasma where veterinarians can choose donor vaccination histories (R. equi, S. equi, Rotavirus, C. difficile, C. perfringens A, Salmonella, E. coli, West Nile Virus, C. botulinum B) and volumes from 900 to 1500 milliliters per unit.

9Protein Volume Replacement PVR
CategoryEquine Biologics - Critical Care Plasma
Description

Lowest cost plasma option for hypoproteinemia or hypovolemic critical care patients containing 30g albumin and 60g total protein per unit for pre and post operative protein replacement.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierPrimaryTypeChannel Partner/ Reseller/ Distributor
Description

MG Biologics moved e-commerce operations to Vetcove platform, enabling free access to a progressive veterinary e-commerce platform. Customers can search products by name or company name on Vetcove. Over 8,000 veterinary hospitals use Vetcove for inventory management and purchasing.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for MG Biologics products including Rattler Antivenom. Part of the distribution network providing products to veterinary clinics.

3Patterson Veterinary
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for MG Biologics products. Provides veterinary supply distribution services.

mgbiologics.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for MG Biologics products including Rattler Antivenom.

5Animal Health International
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for MG Biologics products.

mgbiologics.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for MG Biologics products available through Vetcove platform integration.

7VetOne
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

VetOne distributes Rattler Antivenom. Online purchasing available through VetOne store.

mgbiologics.com
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Texas A&M published research in 2016 and 2019 on Rhodococcus equi hyperimmune plasma. The Gluck Equine Research Center conducted third-party studies comparing commercial R. equi antibody products, finding ReSolution showed 4x higher VapA-specific IgGa than competitors.

Strategic tierNotableTypeStrategic or Co-development Partner
Description

Oklahoma State University conducted research on antivenom effectiveness using mouse model to test neutralization of North American rattlesnake venoms.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Plasvacc USA is a direct competitor producing hyperimmune plasma products for veterinary use, particularly equine Rhodococcus equi antibody products. Highly comparable in product category, manufacturing approach (equine plasma), and target customer base of equine veterinarians.

TypeDirect peer
Description

Lake Immunogenics produces hyperimmune equine plasma products for the veterinary market, including Rhodococcus equi antibody formulations. Closely comparable in plasma-derived antibody manufacturing for equine neonatal care, directly competing on the same product category.

TypeDirect peer
Description

Colorado Serum Company manufactures veterinary biologics including antivenoms and plasma-derived products for animal health. Comparable as a USDA-licensed manufacturer of biologics (especially antivenoms) serving similar veterinary channels.

4Midland BioProducts
TypeDirect peer
Description

Midland BioProducts produces plasma-derived and biologics products for veterinary use, including equine plasma. Comparable as a peer-sized veterinary biologics manufacturer competing in the same equine plasma and antibody categories.

TypeBroad incumbent
Description

Bimeda is a global veterinary pharmaceuticals manufacturer with a broad animal health portfolio including biologics and plasma-derived products. Comparable as a broader incumbent operating in veterinary pharmaceuticals with overlapping product categories.

TypeBroad incumbent
Description

Zoetis is the world's largest animal health company with a broad portfolio including vaccines, parasiticides, and biologics. Comparable as a broad incumbent in animal health that could expand into hyperimmune plasma/equine biologics segments, though it does not currently focus on equine plasma products.

7Boehringer Ingelheim Vetmedica (BIVI)
TypeBroad incumbent
Description

BIVI is a major veterinary pharmaceuticals and biologics manufacturer with equine products including Rhodococcus equi vaccines and treatments. Comparable as a broad incumbent with overlapping interest in equine respiratory disease and broader veterinary biologics.

TypeBroad incumbent
Description

Vetoquinol is a global veterinary pharmaceutical company with products across companion animal and livestock categories, including biologics. Comparable as a broader veterinary pharmaceuticals incumbent that operates in overlapping distribution channels.

TypeBroad incumbent
Description

Dechra is a specialty veterinary pharmaceuticals company with a strong equine and companion animal focus. Comparable as a specialty veterinary pharma incumbent serving similar equine and small animal veterinary channels with biologics and therapeutics.

10VetStem Biopharma
TypeEmerging player
Description

VetStem Biopharma is an emerging regenerative medicine and biologic therapy company in veterinary medicine. Comparable as a smaller, emerging biologics-focused veterinary company that could potentially overlap or expand into adjacent biologic categories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MG Biologics

Veterinary Biologicsmgbiologics.com

MG Biologics firmographics

Firmographics
Name
MG Biologics
Legal name
MG Biologics
Website
https://mgbiologics.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

MG Biologics industry classification

Industry
Product category
Veterinary Biologics
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAMAEAK
Biologics & Immunotherapies (Non-vaccine)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAB
Livestock & Production Animal Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAC
Equine Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

  • Veterinary biologics
  • Equine plasma products
  • Animal antivenom
  • USDA licensed antibodies
  • Hyperimmune plasma manufacturing

Where MG Biologics is headquartered

Location

Headquarters

HQ city
Ames
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MG Biologics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Plasma and Antibody Products: One-time sale of plasma products (equine, canine, bovine, porcine) including USDA licensed products like ReSolution Rhodococcus Equi Antibody and High-Glo Equine IgG. Products sold directly and through distribution partners.
  2. Rattler Antivenom: One-time sale of polyvalent antivenom for Crotalidae snakebites in canine, equine, and feline. Licensed product with three-year shelf life, sold in 50ml treatments.
  3. Custom Blend Plasma: Custom designed ImmunoGlo plasma blends tailored to individual farm/farm veterinarian specifications. Pricing directly related to quantity per unit.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

MG Biologics product offering

Product offering

Core offering

MG Biologics is a USDA-licensed plasma and antibody manufacturer based in Ames, Iowa, that produces hyperimmune plasma products, IgG formulations, and polyvalent antivenom for veterinary use across equine, canine, bovine, porcine, and feline species. The company collects equine plasma from specifically vaccinated donors and manufactures biological products that deliver targeted antibodies to treat or prevent conditions such as Rhodococcus equi pneumonia, Failure of Passive Transfer in foals, Clostridium infections, enteric diseases, and pit viper envenomation.

Product overview

MG Biologics is a USDA-licensed plasma and antibody manufacturer located in Ames, Iowa, offering a comprehensive portfolio of biological products for animal health. The product line centers on plasma-derived antibodies and antivenom products across multiple species including equine, canine, bovine, porcine, and feline. Key products include the ReSolution Rhodococcus Equi Antibody and High-Glo Equine IgG (both USDA licensed), the Rattler Antivenom polyvalent antivenom, TetriCare for tetanus protection, ACDCare for Clostridium perfringens coverage, Immunogut for canine enteric support, and AbSolution PG for porcine use. The ImmunoGlo Custom Blends platform allows veterinarians to design custom plasma formulations by selecting specific donor vaccination histories. Products range from single-pathogen plasmas to complex multi-pathogen blends available in volumes from 50ml to 1500ml.

Differentiator

Problem solved

Functional benefit

Brands

  • ImmunoGlo: Custom blended plasma product line for equine use, allowing veterinarians to design donor vaccination histories.
  • ReSolution
  • High-Glo
  • TetriCare
  • ACDCare
  • AbSolution PG
  • Rattler Antivenom
  • Immunogut

Products and services

  • ReSolution Rhodococcus Equi Antibody USDA-licensed plasma product containing Virulence-Associated Plasmid A (VapA) antibodies with a minimum release titer of 1:10,000, used by veterinarians for prevention and control of Rhodococcus equi pneumonia in foals.
  • High-Glo Equine IgG USDA-licensed intravenous treatment for Failure of Passive Transfer (FPT) in neonatal foals, supplementing IgG through plasma rich in immunoglobulin antibodies.
  • Rattler Antivenom Antivenom Crotalidae Polyvalent Equine Origin that neutralizes venom from rattlesnakes, copperheads, and cottonmouths/water moccasins including Mohave Venom A. Licensed for canine, equine, and feline use with a three-year shelf life.
  • TetriCare Plasma from donors vaccinated against tetanus toxin for wound care management in cattle, horses, goats, sheep, and swine, available in 50 mL bottle and 200 mL IV bag formats.
  • ACDCare Plasma from donors vaccinated against Clostridium perfringens Types A, C & D for cattle, goats, sheep, and swine, supporting gastrointestinal tract during high-stress situations.
  • Immunogut Orally administered plasma from donors vaccinated against E. coli, Parvovirus, Salmonella, and Clostridioides difficile for canine support during enteric distress and high-stress situations.
  • AbSolution PG Plasma from donors vaccinated against Clostridium difficile for porcine use to support intestinal health.
  • ImmunoGlo Custom Blends Custom blended equine plasma where veterinarians can choose donor vaccination histories (R. equi, S. equi, Rotavirus, C. difficile, C. perfringens A, Salmonella, E. coli, West Nile Virus, C. botulinum B) and volumes from 900 to 1500 milliliters per unit.
  • Protein Volume Replacement PVR Lowest cost plasma option for hypoproteinemia or hypovolemic critical care patients containing 30g albumin and 60g total protein per unit for pre and post operative protein replacement.

Quantifiable outcome

  • 80% protection against R. equi pneumonia with 2L hyperimmune plasma vs 68% with 1L
  • +4 more outcomes

Companies that use MG Biologics

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles4 records

MG Biologics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

MG Biologics partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered primary, core and notable.

  • VetcoveprimaryChannel Partner/ Reseller/ DistributorMG Biologics moved e-commerce operations to Vetcove platform, enabling free access to a progressive veterinary e-commerce platform. Customers can search products by name or company name on Vetcove. Over 8,000 veterinary hospitals use Vetcove for inventory management and purchasing.
  • MWI Veterinary SupplycoreChannel Partner/ Reseller/ DistributorDistribution partner for MG Biologics products including Rattler Antivenom. Part of the distribution network providing products to veterinary clinics.
  • Patterson VeterinarycoreChannel Partner/ Reseller/ DistributorDistribution partner for MG Biologics products. Provides veterinary supply distribution services.
  • Midwest Veterinary SupplycoreChannel Partner/ Reseller/ DistributorDistribution partner for MG Biologics products including Rattler Antivenom.
  • Animal Health InternationalcoreChannel Partner/ Reseller/ DistributorDistribution partner for MG Biologics products.
  • CovetruscoreChannel Partner/ Reseller/ DistributorDistribution partner for MG Biologics products available through Vetcove platform integration.
  • VetOnecoreChannel Partner/ Reseller/ DistributorVetOne distributes Rattler Antivenom. Online purchasing available through VetOne store.
  • Texas A&M University (Gluck Equine Research Center)notableStrategic or Co-development PartnerTexas A&M published research in 2016 and 2019 on Rhodococcus equi hyperimmune plasma. The Gluck Equine Research Center conducted third-party studies comparing commercial R. equi antibody products, finding ReSolution showed 4x higher VapA-specific IgGa than competitors.
  • Oklahoma State UniversitynotableStrategic or Co-development PartnerOklahoma State University conducted research on antivenom effectiveness using mouse model to test neutralization of North American rattlesnake venoms.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

MG Biologics competitors and assessment

Company assessment

Direct peers

  • Plasvacc USA: Plasvacc USA is a direct competitor producing hyperimmune plasma products for veterinary use, particularly equine Rhodococcus equi antibody products. Highly comparable in product category, manufacturing approach (equine plasma), and target customer base of equine veterinarians.
  • Lake Immunogenics: Lake Immunogenics produces hyperimmune equine plasma products for the veterinary market, including Rhodococcus equi antibody formulations. Closely comparable in plasma-derived antibody manufacturing for equine neonatal care, directly competing on the same product category.
  • Colorado Serum Company: Colorado Serum Company manufactures veterinary biologics including antivenoms and plasma-derived products for animal health. Comparable as a USDA-licensed manufacturer of biologics (especially antivenoms) serving similar veterinary channels.
  • Midland BioProducts: Midland BioProducts produces plasma-derived and biologics products for veterinary use, including equine plasma. Comparable as a peer-sized veterinary biologics manufacturer competing in the same equine plasma and antibody categories.

Broad incumbents

  • Bimeda: Bimeda is a global veterinary pharmaceuticals manufacturer with a broad animal health portfolio including biologics and plasma-derived products. Comparable as a broader incumbent operating in veterinary pharmaceuticals with overlapping product categories.
  • Zoetis: Zoetis is the world's largest animal health company with a broad portfolio including vaccines, parasiticides, and biologics. Comparable as a broad incumbent in animal health that could expand into hyperimmune plasma/equine biologics segments, though it does not currently focus on equine plasma products.
  • Boehringer Ingelheim Vetmedica (BIVI): BIVI is a major veterinary pharmaceuticals and biologics manufacturer with equine products including Rhodococcus equi vaccines and treatments. Comparable as a broad incumbent with overlapping interest in equine respiratory disease and broader veterinary biologics.
  • Vetoquinol: Vetoquinol is a global veterinary pharmaceutical company with products across companion animal and livestock categories, including biologics. Comparable as a broader veterinary pharmaceuticals incumbent that operates in overlapping distribution channels.
  • Dechra Pharmaceuticals: Dechra is a specialty veterinary pharmaceuticals company with a strong equine and companion animal focus. Comparable as a specialty veterinary pharma incumbent serving similar equine and small animal veterinary channels with biologics and therapeutics.

Emerging players

  • VetStem Biopharma: VetStem Biopharma is an emerging regenerative medicine and biologic therapy company in veterinary medicine. Comparable as a smaller, emerging biologics-focused veterinary company that could potentially overlap or expand into adjacent biologic categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MG Biologics social profiles

Digital presence

MG Biologics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MG Biologics leadership team

Management profile

Number of profiles

Profiles2 records

MG Biologics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MG Biologics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MG Biologics

What does MG Biologics do?

MG Biologics is a USDA-licensed plasma and antibody manufacturer based in Ames, Iowa, that produces hyperimmune plasma products, IgG formulations, and polyvalent antivenom for veterinary use across equine, canine, bovine, porcine, and feline species. The company collects equine plasma from specifically vaccinated donors and manufactures biological products that deliver targeted antibodies to treat or prevent conditions such as Rhodococcus equi pneumonia, Failure of Passive Transfer in foals, Clostridium infections, enteric diseases, and pit viper envenomation.

Is MG Biologics a public or private company?

MG Biologics is a private company. It is classified as family owned and is currently operating.

When was MG Biologics founded?

MG Biologics was founded in 1999. It employs 11 to 50 people.

Where is MG Biologics based?

MG Biologics is headquartered in Ames, United States, in the North America region.

How does MG Biologics make money?

Three revenue lines are on record. Plasma and Antibody Products are the primary driver. The others are rattler Antivenom and custom Blend Plasma.

Who are MG Biologics's main competitors?

Direct peers on record are Plasvacc USA, Lake Immunogenics, Colorado Serum Company and Midland BioProducts. Broad incumbents are Bimeda, Zoetis, Boehringer Ingelheim Vetmedica (BIVI), Vetoquinol and Dechra Pharmaceuticals. VetStem Biopharma is listed as an emerging player.

Does MG Biologics have an API?

No public API is recorded for MG Biologics.

What industry is MG Biologics in?

MG Biologics's product category is Veterinary Biologics. Its primary akta.pro industry code is HLAMAEAK, Biologics & Immunotherapies (Non-vaccine), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales